These effects reflect “hot tumor” features, including increased CD8+ T cell infiltration, upregulation of immune checkpoint molecules (PD-1 and CTLA-4), and activation of the IFN-γ pathway (81, 82). The gene discussed is CTLA4; the disease is neoplasm.